Price $372.04 |
Market Cap
24.25B
|
Sector Health Care |
Div. Growth
5.60%
|
|
P/E
45.4
|
P/B
8.68
|
P/S
8.51
|
Dividend %
0.20%
|
|
P/CF
149.0
|
P/FCF
69.5
|
Op. Cash Flow
768.2K
|
FCF
4.8
|
|
Op. Margin
22.00%
|
Net Margin
19.10%
|
ROE
20.20%
|
ROI
19.40%
|
|
ROA
15.20%
|
EPS Growth
-10.90%
|
Current Ratio
3.7
|
Debt/Equity
7.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals Inc (RIGL) | $1.08 | - | - | 139.2M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $0.68 | - | - | 78M | Strong Buy |
| CYANOTECH CORP (CYAN) | $0.35 | - | - | 4.4M | Strong Buy |
| Chromadex Corp (CDXC) | $3.69 | - | - | 105.8M | Strong Buy |
| Generation Bio Co (GBIO) | $2.80 | - | - | 65.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
